Israel Englander Omega Therapeutics, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 520,898 shares of OMGA stock, worth $5,208. This represents 0.0% of its overall portfolio holdings.

Number of Shares

520,898

Previous 535,616 2.75%

Holding current value

$5,208

Previous $653,000 40.28%

% of portfolio

0.0%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.75 - $1.45 $11,038 - $21,341	-14,718 Reduced 2.75%	520,898 $390,000
Q3 2024 Nov 14, 2024	SELL	$1.22 - $2.25 $266,700 - $491,865	-218,607 Reduced 28.98%	535,616 $653,000
Q2 2024 Aug 14, 2024	BUY	$1.86 - $3.2 $794,365 - $1.37 Million	427,078 Added 130.55%	754,223 $1.56 Million
Q1 2024 May 15, 2024	BUY	$2.73 - $5.32 $820,946 - $1.6 Million	300,713 Added 1137.69%	327,145 $1.19 Million
Q4 2023 Feb 14, 2024	SELL	$1.35 - $3.21 $82,977 - $197,302	-61,465 Reduced 69.93%	26,432 $79,000
Q2 2023 Aug 14, 2023	SELL	$5.6 - $9.66 $705,000 - $1.22 Million	-125,893 Reduced 58.89%	87,897 $492,000
Q1 2023 May 15, 2023	BUY	$4.81 - $10.95 $850,345 - $1.94 Million	176,787 Added 477.76%	213,790 $1.29 Million
Q4 2022 Feb 14, 2023	BUY	$4.22 - $7.05 $84,328 - $140,880	19,983 Added 117.41%	37,003 $211,000
Q3 2022 Nov 14, 2022	SELL	$3.63 - $6.65 $753,417 - $1.38 Million	-207,553 Reduced 92.42%	17,020 $92,000

Others Institutions Holding OMGA

# of Institutions

Shares Held

42.6M

Call Options Held

24.6K

Put Options Held

5.8K

View Full List

About Omega Therapeutics, Inc.

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $479K
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

More about OMGA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account